Randomized Prospective Clinical Study of Spatz3® Adjustable Intragastric Balloon Treatment with a Control Group: a Large-Scale Brazilian Experiment.

Ricardo José Fittipaldi-FernandezIdiberto José Zotarelli-FilhoCristina Fajardo DiestelMárcia Regina Simas Torres KleinMarcelo Falcão de SantanaJoão Henrique Felicio de LimaFernando Santos Silva BastosNewton Teixeira Dos Santos

Published in: Obesity surgery (2020)

This study shows that Spatz3® IGB treatment is an effective procedure for weight reduction, with no mortality but higher morbidity compared with traditional IGBs. This procedure also enabled the balloon to stay in place for longer. The efficacy of upward adjustment still requires further confirmation.

Keyphrases

double blind
minimally invasive
body mass index
type diabetes
open label
weight loss
combination therapy
replacement therapy